Giant cell arteritis is a rare, but urgent and potentially life-threatening, presentation that can have ocular consequences. This course details how to tell which patients are likely to have it based on their history and symptoms as well as how to test for it using both imaging and lab work, and reviews the optometrist’s role in treating and comanaging these patients.
It’s no secret that Americans are in the midst of a substance abuse crisis. As primary care physicians, optometrists can play a role in recognizing damage or dysfunction to either ocular structures or the components of the visual pathway these drugs cause and counseling patients in these circumstances. This article reviews commonly used legal and illicit substances, and how each are associated with the formation, or exaggeration, of disease or damage.
While optometrists are fortunate to have an expanding armamentarium, artificial tears remain an integral part of the basic management strategy as a recommended first-line option. Although they do not directly address the underlying etiology of dry eye, artificial tears can effectively control symptoms and may be the primary therapeutic component for many with mild or episodic dry eye.
In October 2017, several leading educators and private practice clinicians published the “Practical Guidelines for the Treatment of AMD” in Review of Optometry.
In this follow-up guide, practitioners review what they’ve learned since the Guidelines were first published; and based on extensive feedback, this committee will share practical advice for successful implementation of the Guidelines in your own practice.